Sanofi announces €300 million collaboration with Blackstone Life Sciences MD Bureau17 March 2022 10:43 AM ISTFor the Sarclisa subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections, Inc. to...
PET/CT helps assess early treatment response in multiple myeloma patients Medha Baranwal11 March 2022 9:00 AM ISTUSA: A recent study in the journal Blood Advances reveals that PET/CT can help in predicting which patients have better survival chances after...
Janssen Pharma seeks USFDA nod for Teclistamab to treat multiple myeloma Ruchika Sharma30 Dec 2021 11:15 AM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S....
Study finds role of selenium in prevention of cancer Dr. Nandita Mohan28 Dec 2021 2:46 PM ISTAccording to a new study, having a high selenium level may not prevent the development of cancer. The links between kidney cancer and multiple myeloma...
Medical Bulletin 27/December/2021 Dr. Nandita Mohan27 Dec 2021 5:23 PM ISTHere are Top Medical stories of the dayGender Differences In Hypertension Control Widen With Advancing AgeCardiovascular disease is the leading cause...
Will higher Selenium status prevent Cancer risk? MD Editorial Team22 Dec 2021 9:00 AM ISTAccording to a new study, having a high selenium level may not prevent the development of cancer. The links between kidney cancer and multiple myeloma...
Multiple Myeloma: Diagnosis, Prevention and Treatment Dr Meet Kumar22 Nov 2021 12:52 PM ISTMultiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help you fight infections by making...
Natco Pharma arm launches first generic alternative to Revlimid in Canada Medical Dialogues Team2 Sept 2021 4:28 PM ISTNew Delhi: Natco Pharma (Canada), a subsidiary of Natco Pharma Limited, announced the launch of PrNat-Lenalidomide Capsules, the first generic...
Aurobindo Pharma arm gets USFDA okay for Cyclophosphamide Injection Ruchika Sharma27 Aug 2021 1:19 PM ISTHyderabad: Aurobindo Pharma Limited today announced that the company's subsidiary Eugia Pharma Specialities Ltd. has received a 505(b)(2) NDA...
Beta blockers show promise in managing multiple myeloma: European Journal of Haematology Dr Satabdi Saha7 July 2021 9:00 AM ISTBeta blockers when used synergistically with an immunomodulatory drug, Pomalidomide, has been reported to improve survival rates in patients with...
FDA approves cellular gene therapy for refractory multiple myeloma Dr Satabdi Saha5 April 2021 10:53 AM ISTIn a recent development,FDA has given a nod to the first gene therapy for patients of relapsed or refractory multiple myeloma who have received at...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
